Breast Cancer
Conditions
Keywords
Breast cancer, Palbociclib, Memorial Sloan Kettering Cancer Center, 19-458
Brief summary
The purpose of this study is to find out whether it is feasible (acceptable to participants) to use a smartphone app to send text message reminders to take palbociclib, and whether these reminders are effective at helping people remember to take palbociclib according to the treatment schedule.
Interventions
OTHERPaper Drug Diary
Participants will receive and use a paper Drug Diary and a paper medication calendar.
OTHEROhMD APP
Participants will receive multiple text messages regarding administration over time on medication self-management over the course of 3 cycles of medication
Sponsors
Memorial Sloan Kettering Cancer Center
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients with a breast cancer diagnosis who are initiating therapy on palbociclib (Ibrance) * \>/= 18 years of age * Able to speak, read and write English * Willingness and ability to send and receive text messages with intervention app * Own a mobile telephone "smartphone" with text messaging capabilities. Only iPhone or Android operating systems support OhMD Application * Criteria applicable for both Control and Intervention groups * Flip-phones do not support OhMD Application and thus ineligible to participate * Initiation palbociclib (Ibrance) for the first time, either as monotherapy or in conjunction with other medication such as Lstrozole (Femara) or Fulvestrant (Faslodex)
Exclusion criteria
* History of taking palbociclib (Ibrance) * Patients whose caregivers coordinate their health care
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Accuracy rate of medication self-administration | Up to 1 year | The effectiveness of a mobile technology intervention by calculating the proportion of the number of days that the participant accurately self-administers the medication divided by the number of days the medication should have been taken |
Countries
United States
Contacts
PRINCIPAL_INVESTIGATORMargaret Barton-Burke, PhD, RN
Memorial Sloan Kettering Cancer Center
Outcome results
None listed